Debra Travers is President and CEO of PolyAurum LLC. She comes to PolyAurum after a 30+ year career as an accomplished strategic healthcare executive and entrepreneur with diverse and progressive product development and commercialization experience in global pharmaceutical and biomedical companies, including Centocor, GSK, Endo Pharmaceuticals and IMS Health. She has extensive experience in commercial assessment, technical development, registration, launch and life cycle management for life sciences products and services.
Dr. David Cormode is an Assistant Professor in the Department of Radiology. He has over 10 years of experience in the development of novel metal nanoparticles. He has published over 60 papers, primarily on the topic of nanoparticle contrast agents.
Dr. Rabe’e Cheheltani is a postdoctoral fellow in the Department of Radiology. Her research is focused on nanoparticles as contrast agents in medical imaging. Her previous experiences include nanoparticles for targeted drug delivery, as well as imaging methods for characterizing the structure of cardiovascular tissue.
Dr. Jay Dorsey is an Assistant Professor of Radiation Oncology and an NIH-funded physician-scientist. He is a board-certified Radiation Oncologist with expertise in CNS cancers and radiosurgery. He is PI of a translational research laboratory focused on theranostic agent development and tumor biomarkers.
Prof. Andrew Tsourkas is a Professor of Bioengineering and is the Associate Director for the Center for Targeted Therapeutics and Translational Nanomedicine. He has 15 years of experience in the development of nanoparticles for both therapeutic and imaging applications.